Meeting
2022 ASCO Annual Meeting
Inpatient complications of immunotherapy-associated colitis in solid malignancies: Real-world data analysis.
Authors
Rayli Pichardo
Henry Ford Hospital, Detroit, MI
Rayli Pichardo , Yazan Abu Omar , Ding Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Other IO-Related Topics
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 2657)
DOI
10.1200/JCO.2022.40.16_suppl.2657
Abstract #
2657
Poster Bd #
311
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Real-world use and clinical impact of electronic patient-reported outcomes (ePROs) in patients with solid tumors treated with immuno-oncology (IO) therapy.
First Author: Natalie R. Dickson
Poster
2022 ASCO Quality Care Symposium
The Inpatient Immunotherapy Outcomes study: A multicenter retrospective study of patients treated with immune checkpoint inhibitors in the inpatient setting.
First Author: Fauzia Riaz
Poster
2020 ASCO Quality Care Symposium
Real-world patterns of chemotherapy and immunotherapy utilization at end of life in a large community oncology network.
First Author: Stephen Matthew Schleicher
Poster
2024 ASCO Annual Meeting
Trend and burden of cancer related hospitalizations in the US: Insights from a National Inpatient Sample Database analysis.
First Author: Rohit Singh